NANOG and cancer: Results of immunoblots assay had shown that SCD1 elevated the expression of cancer stemness related markers (CD44, Nanog, Sox2 and CD90) (Figure 4L), while the reverse tendency had been observed in SCD1 silencing groups (Figure 4K), elucidating the mechanism by which SCD1 ameliorate the metastasis of gastric cancer more intuitively.